Recent News


Teva Announces Sale of Pennsylvania Facility

Teva Pharmaceutical Industries Ltd. (NYSE,TASE:TEVA) has signed an agreement to sell its Sellersville, Pennsylvania facility to G&W Laboratories, Inc., salvaging 280 employees’  jobs and further streamlining its own operations by reducing excess manufacturing ...

Read More »

Evogene to Build Research Facility in the United States

Rehovot-based Evogene is establishing an R&D facility in St. Louis, Missouri. The central focus of the facility will be Evogene’s existing insect control program and it will be headed by Dr. James Presnail, ...

Read More »

MediWound to Ring the NASDAQ Stock Market Closing Bell in Recognition of Burn Awareness Week

MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, announced that Gal Cohen, MediWound’s Chief Executive Officer, will ring ...

Read More »

Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option

After its stock dropped over 80% last year with failed Phase III trial results, Alcobra has raised approximately $27.9 million in a public offering of ordinary shares. The full over allotment ...

Read More »


Medical Devices